Pharmaron Beijing Co., Ltd. Class H (HK:3759)
:3759
Total Valuation
Pharmaron Beijing Co., Ltd. Class H has a market cap or net worth of HK$58.22B. The enterprise value is HK$47.53B.
Market CapHK$58.22B
Enterprise ValueHK$47.53B
Share Statistics
Pharmaron Beijing Co., Ltd. Class H has 359,977,870 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding359,977,870
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharmaron Beijing Co., Ltd. Class H’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.84%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.84%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee659.57K
Profits Per Employee72.77K
Employee Count21,370
Asset Turnover0.52
Inventory Turnover6.24
Valuation Ratios
The current PE Ratio of Pharmaron Beijing Co., Ltd. Class H is 18.6. Pharmaron Beijing Co., Ltd. Class H’s PEG ratio is -2.69.
PE Ratio18.6
PS Ratio2.20
PB Ratio2.06
Price to Fair Value2.06
Price to FCF56.17
Price to Operating Cash Flow16.66
PEG Ratio-2.69
Income Statement
In the last 12 months, Pharmaron Beijing Co., Ltd. Class H had revenue of 14.10B and earned 1.66B in profits. Earnings per share was 0.94.
Revenue14.10B
Gross Profit4.91B
Operating Income1.93B
Pretax Income1.91B
Net Income1.66B
EBITDA3.29B
Earnings Per Share (EPS)0.94
Cash Flow
In the last 12 months, operating cash flow was 3.25B and capital expenditures -2.68B, giving a free cash flow of 564.76M billion.
Operating Cash Flow3.25B
Free Cash Flow564.76M
Free Cash Flow per Share1.57
Dividends & Yields
Pharmaron Beijing Co., Ltd. Class H pays an annual dividend of HK$0.219, resulting in a dividend yield of 1.04%
Dividend Per ShareHK$0.219
Dividend Yield1.04%
Payout Ratio23.78%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.98
52-Week Price Change71.50%
50-Day Moving Average19.88
200-Day Moving Average21.60
Relative Strength Index (RSI)59.54
Average Volume (3m)3.76M
Important Dates
Pharmaron Beijing Co., Ltd. Class H upcoming earnings date is Apr 23, 2026, TBA (Not Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateApr 23, 2026
Ex-Dividend Date―
Financial Position
Pharmaron Beijing Co., Ltd. Class H as a current ratio of 0.93, with Debt / Equity ratio of 22.68%
Current Ratio0.93
Quick Ratio0.75
Debt to Market Cap0.10
Net Debt to EBITDA0.73
Interest Coverage Ratio10.00
Taxes
In the past 12 months, Pharmaron Beijing Co., Ltd. Class H has paid 357.52M in taxes.
Income Tax357.52M
Effective Tax Rate0.19
Enterprise Valuation
Pharmaron Beijing Co., Ltd. Class H EV to EBITDA ratio is 10.16, with an EV/FCF ratio of 60.52.
EV to Sales2.37
EV to EBITDA10.16
EV to Free Cash Flow60.52
EV to Operating Cash Flow10.37
Balance Sheet
Pharmaron Beijing Co., Ltd. Class H has HK$1.73B in cash and marketable securities with HK$3.42B in debt, giving a net cash position of -HK$1.69B billion.
Cash & Marketable SecuritiesHK$1.73B
Total DebtHK$3.42B
Net Cash-HK$1.69B
Net Cash Per Share-HK$4.68
Tangible Book Value Per ShareHK$6.22
Margins
Gross margin is 34.57%, with operating margin of 13.68%, and net profit margin of 11.80%.
Gross Margin34.57%
Operating Margin13.68%
Pretax Margin13.57%
Net Profit Margin11.80%
EBITDA Margin23.32%
EBIT Margin14.94%
Analyst Forecast
The average price target for Pharmaron Beijing Co., Ltd. Class H is HK$29.93, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$29.93
Price Target Upside24.00% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast14.50%
EPS Growth Forecast-19.24%